decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / OCULAR_PHOTODYNAMIC_THERAPY_(OPT)_-_Effective_April_1,_2004
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare national coverage determination update for ocular photodynamic therapy (OPT) with verteporfin. It explains the scope of coverage for age-related macular degeneration, identifies categories of covered and noncovered clinical scenarios, and notes that some other ocular uses may be handled under local coverage determinations. The content is relevant to ophthalmology, medical coding, and reimbursement professionals who need to understand how this therapy is addressed in CMS coverage policy.
Why This Topic Matters
Coverage policy for ophthalmic procedures can affect claim payment, documentation, and medical necessity review. Understanding which broad clinical situations are addressed in national policy versus local contractor discretion helps providers and coders align records with Medicare requirements.
Article Sections
-
General
Introduces the therapy, the clinical area it addresses, and the overall coverage context described in the policy update. It also summarizes the historical policy background leading into the later sections.
-
Covered Indications
Outlines the categories of clinical situations addressed as covered under the policy and describes the general conditions tied to those covered scenarios. This section also references follow-up treatment considerations and documentation-related requirements.
-
Noncovered Indications
Describes groups of age-related macular degeneration scenarios that remain outside national coverage under the policy. It identifies types of circumstances that are not addressed as covered in this determination.
-
Other
Notes that certain other ocular uses may be considered under local coverage determinations rather than this national policy. It also includes the review date for the determination.
What You Will Learn
- What the policy update covers at a high level
- Which broad ocular and retinal scenarios are addressed in national coverage
- How the article distinguishes covered, noncovered, and locally handled uses
- What kinds of policy background and effective dates are referenced
Who Should Read This
- Medical coders
- Coding auditors
- Ophthalmology providers
- Billing staff
- Revenue cycle professionals
- Compliance teams
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com